We are live on ! Find out more
DG

Delek Group Portfolio holdings

AUM $2.59B
1-Year Est. Return 1.24%
This Fund
S&P 500
This Quarter Est. Return
-16.41%
1 Year Est. Return
-1.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$191M
Cap. Flow
+$144M
Cap. Flow %
6.58%
Top 10 Hldgs %
23.34%
Holding
263
New
37
Increased
74
Reduced
71
Closed
47
Avg Time Held Equity + Options
2.9 quarters
Top 10 Avg Time Held Equity + Options
2.2 quarters
Top 20 Avg Time Held Equity + Options
2.6 quarters
Avg Time Held Equity only
3 quarters
Top 10 Avg Time Held Equity only
2.2 quarters
Top 20 Avg Time Held Equity only
2.6 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.98%
2 Technology 16.06%
3 Healthcare 14.03%
4 Materials 8.78%
5 Energy 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
URGN icon
101
UroGen Pharma
URGN
$1.87B
$7.23M 0.33%
163,435
+63,815
+64% +$2.87M
2018 Q3
1 quarter
AQ
102
DELISTED
Aquantia Corp. Common Stock
AQ
$7.16M 0.33%
795,533
+435,344
+121% +$4.41M
2018 Q2
2 quarters
IFF icon
103
CALL
International Flavors & Fragrances
IFF
$22.5B
$7.12M 0.32%
+53,000
New +$7.33M
2018 Q4
0 quarters
NCMI icon
104
National CineMedia
NCMI
$208M
$6.99M 0.32%
104,968
+46,450
+79% +$3.65M
2018 Q2
2 quarters
HBAN icon
105
Huntington Bancshares
HBAN
$30.8B
$6.79M 0.31%
550,000
– –
2017 Q4
4 quarters
MLNX
106
CALL
DELISTED
Mellanox Technologies, Ltd.
MLNX
$6.66M 0.3%
72,100
-79,300
-52% -$6.74M
2017 Q4
4 quarters
META icon
107
PUT
Meta Platforms (Facebook)
META
$1.94T
$6.55M 0.3%
+50,000
New +$7.24M
2018 Q4
0 quarters
PAGP icon
108
Plains GP Holdings
PAGP
$5.36B
$6.23M 0.28%
302,000
– –
2018 Q2
2 quarters
DY icon
109
Dycom Industries
DY
$8.13B
$6.1M 0.28%
110,000
– –
2018 Q2
2 quarters
PRGO icon
110
PUT
Perrigo
PRGO
$2.13B
$6.09M 0.28%
155,100
-11,600
-7% -$736K
2017 Q4
4 quarters
CELG
111
CALL
DELISTED
Celgene Corp
CELG
$6.09M 0.28%
95,000
– –
2018 Q2
2 quarters
CELG
112
PUT
DELISTED
Celgene Corp
CELG
$6.09M 0.28%
+95,000
New +$7.01M
2018 Q4
0 quarters
NVS icon
113
Novartis
NVS
$271B
$6.06M 0.28%
76,714
-22,320
-23% -$1.74M
2017 Q4
4 quarters
DFS icon
114
DELISTED
Discover Financial Services
DFS
$5.81M 0.27%
96,000
– –
2017 Q4
4 quarters
ONDK
115
DELISTED
On Deck Capital, Inc.
ONDK
$5.76M 0.26%
950,819
– –
2017 Q4
4 quarters
CEL
116
DELISTED
Cellcom Israel, Ltd.
CEL
$5.73M 0.26%
1,001,107
+318,406
+47% +$2.08M
2017 Q4
4 quarters
XLU icon
117
State Street Utilities Select Sector SPDR ETF
XLU
$24.3B
$5.42M 0.25%
+201,420
New +$5.47M
2018 Q4
0 quarters
HAIN icon
118
Hain Celestial
HAIN
$52M
$5.31M 0.24%
325,933
– –
2017 Q4
4 quarters
GOVT icon
119
iShares US Treasury Bond ETF
GOVT
$41.8B
$5.21M 0.24%
208,566
+161,696
+345% +$3.93M
2017 Q4
4 quarters
VIAB
120
DELISTED
Viacom Inc. Class B
VIAB
$5.08M 0.23%
191,594
-150,000
-44% -$4.62M
2017 Q4
4 quarters
OKE icon
121
Oneok
OKE
$58.9B
$4.71M 0.21%
85,000
– –
2018 Q2
2 quarters
TSEM icon
122
CALL
Tower Semiconductor
TSEM
$25.1B
$4.65M 0.21%
315,600
-19,900
-6% -$332K
2017 Q4
4 quarters
WFC icon
123
Wells Fargo
WFC
$244B
$4.64M 0.21%
98,053
-230
-0.2% -$11.8K
2017 Q4
4 quarters
GE icon
124
GE Aerospace
GE
$319B
$4.55M 0.21%
122,149
– –
2017 Q4
4 quarters
WMB icon
125
Williams Companies
WMB
$91.2B
$4.51M 0.21%
199,000
– –
2018 Q2
2 quarters

Similar funds

Delek Group's Q4 2018 Portfolio in Review

As of Q4 2018, Delek Group held 263 positions worth $2.19B, down 8% from $2.38B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Delek Group deployed $144M of net new capital in Q4 2018, opening 37 new positions and adding to 74 existing holdings. Its largest new stake was DuPont de Nemours: 177,858 shares worth $24.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $30.8M trimmed.

  • Delek Group's largest Q4 2018 buy was DuPont de Nemours: 177,858 shares worth $24.7M.
  • Delek Group added most to Teva Pharmaceutical Industries Limited in Q4 2018, an estimated $36.2M increase.
  • Delek Group's biggest Q4 2018 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $30.8M.
  • Delek Group fully exited Orbotech Ltd in Q4 2018, selling an estimated $46.5M.
  • Delek Group's ten largest holdings make up 23% of its $2.19B portfolio in Q4 2018.
  • Delek Group opened 37 new positions and closed 47 in Q4 2018.
  • Delek Group's portfolio value fell 8% quarter-over-quarter to $2.19B.

Based on Delek Group's 13F filing for Q4 2018, filed 14 Feb 2019.